Advertisement
Screener

TECTONIC THERAPEUTIC, INC. (TECX) Material Contracts

TECTONIC THERAPEUTIC, INC. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-02-26: Form 10-K; Exhibit 10.4; Description Non-Employee Director Compensation Policy of Tectonic Therapeutic, Inc..
  • 2025-03-20: Form 10-K; Exhibit 10.17; Description Offer Letter dated May 28, 2024, by and between Tectonic Therapeutic, Inc. and Daniel Lochner..
  • 2025-02-03: Form 8-K; Exhibit 10.2; Description Form of Registration Rights Agreement..
  • 2025-02-03: Form 8-K; Exhibit 10.1; Description Form of Securities Purchase Agreement..
FiledFormExhibitDescription
2026-02-2610-K10.4Non-Employee Director Compensation Policy of Tectonic Therapeutic, Inc.
2025-03-2010-K10.17Offer Letter dated May 28, 2024, by and between Tectonic Therapeutic, Inc. and Daniel Lochner.
2025-02-038-K10.2Form of Registration Rights Agreement.
2025-02-038-K10.1Form of Securities Purchase Agreement.
2024-11-1210-Q10.1Non-Employee Director Compensation Policy of Tectonic Therapeutic, Inc.
2024-07-058-K10.1Separation Agreement, dated July 5, 2024, between Tectonic Therapeutic, Inc. and Christian Cortis.
2024-06-208-K10.8Tectonic Therapeutic, Inc. 2024 Employee Stock Purchase Plan.
2024-06-208-K10.7Forms of Option Grant Notice, Option Agreement and Notice of Exercise under Tectonic Therapeutic, Inc. 2024 Equity Incentive Plan.
2024-06-208-K10.6Tectonic Therapeutic, Inc. 2024 Equity Incentive Plan.
2024-06-208-K10.4Amended and Restated Employment Agreement, dated as of June 20, 2024, by and between Tectonic Therapeutic, Inc. and Alise Reicin, M.D.
2024-06-208-K10.3Subscription Agreement, dated as of January 30, 2024, by and among Tectonic and the purchasers thereunder.
2024-06-208-K10.2Form of Indemnification Agreement between Tectonic Therapeutic, Inc. and each of its directors and executive officers.
2024-06-208-K10.1Contingent Value Rights Agreement dated June 20, 2024, by and between Tectonic Therapeutic, Inc. and Computershare Trust Company, LLC.
2024-01-308-K10.4Form of Contingent Value Rights Agreement
2024-01-308-K10.3Form of Lock-Up Agreement
2024-01-308-K10.2Form of AVRO Support Agreement
2024-01-308-K10.1Form of Tectonic Support Agreement
2023-08-1010-Q10.4Executive Retention Payment Agreement, by and between the Registrant and Essra Ridha dated June 26, 2023
2023-08-1010-Q10.3Executive Retention Payment Agreement, by and between the Registrant and Azadeh Golipour dated June 26, 2023
2023-08-1010-Q10.2Executive Retention Payment Agreement, by and between the Registrant and Steven Avruch dated June 26, 2023
2023-08-1010-Q10.1Executive Retention Payment Agreement, by and between the Registrant and Erik Ostrowski dated June 26, 2023
2022-08-0910-Q10.3Amended and Restated Master Services Agreement, by and between the Registrant and Miltenyi Biotec, Inc., dated November 20, 2021.
2022-06-108-K10.1Second Amendment to the AVROBIO, Inc. 2018 Stock Option and Incentive Plan
2022-05-1010-Q10.1Amendment No. 2 to Employment Agreement, dated April 25, 2022, by and between the Registrant and Chris Mason.
2022-03-1710-K10.22Employment Agreement, by and between the Registrant and Essra Ridha, dated October 6, 2021
2021-11-0410-Q10.1Loan and Security Agreement, dated November 2, 2021, by and among the Registrant, the lenders party thereto from time to time and Silicon Valley Bank, as administrative agent and collateral agent.
2021-05-1310-Q10.6AMENDMENT TO EMPLOYMENT AGREEMENT, BY AND BETWEEN THE REGISTRANT AND DEANNA PETERSEN, DATED APRIL 5, 2021.
2021-05-1310-Q10.5AMENDMENT TO EMPLOYMENT AGREEMENT, BY AND BETWEEN THE REGISTRANT AND CHRIS MASON, DATED APRIL 5, 2021.
2021-05-1310-Q10.4AMENDMENT TO EMPLOYMENT AGREEMENT, BY AND BETWEEN THE REGISTRANT AND DIANA ESCOLAR, MD, DATED APRIL 5, 2021.
2021-05-1310-Q10.3AMENDMENT TO EMPLOYMENT AGREEMENT, BY AND BETWEEN THE REGISTRANT AND STEVEN AVRUCH, DATED APRIL 5, 2021.
2021-05-1310-Q10.2AMENDMENT TO EMPLOYMENT AGREEMENT, BY AND BETWEEN THE REGISTRANT AND ERIK OSTROWSKI, DATED APRIL 5, 2021.
2021-05-1310-Q10.1AMENDMENT TO EMPLOYMENT AGREEMENT, BY AND BETWEEN THE REGISTRANT AND GEOFF MACKAY, DATED APRIL 5, 2021.
2021-03-1810-K10.252020 Inducement Plan and form of award agreement thereunder
2021-03-1810-K10.20Employment Agreement, by and between the Registrant and Diana Escolar, dated December 4, 2020
2021-03-1810-K10.19Employment Agreement, by and between the Registrant and Chris Mason, dated September 1, 2018
2020-08-0610-Q10.2Separation Agreement and Release, by and between the Registrant and Birgitte Volck, M.D., Ph.D., dated July 16, 2020.
2020-06-098-K10.1First Amendment to the AVROBIO, Inc. 2018 Stock Option and Incentive Plan.
2020-03-1610-K10.16Employment Agreement, by and between the Registrant and Deanna Petersen, dated September 1, 2018
2020-03-1610-K10.8Amendment No. 2 to License Agreement, by and between the Registrant and BioMarin Pharmaceutical Inc., dated January 7, 2020
2020-03-1610-K10.7Amendment No. 1 to License Agreement, by and between the Registrant and BioMarin Pharmaceutical Inc., dated February 21, 2018
2019-03-2510-K10.15Employment Agreement, by and between the Registrant and Birgitte Volck, M.D., Ph.D., dated December 17, 2018
2019-03-2510-K10.14Consulting Agreement, by and between the Registrant and Birgitte Volck, M.D., Ph.D., dated December 17, 2018
2019-03-2510-K10.13Employment Agreement, by and between the Registrant and Steven Avruch, dated December 17, 2018
2019-01-118-K/A10.2Separation Agreement and Release, dated January 10, 2019, by and between the Company and Nerissa Kreher, M.D.
2019-01-118-K/A10.1Separation Agreement and Release, dated January 8, 2019, by and between the Company and Katina Dorton.
2018-12-218-K10.1Employment Agreement, dated December 17, 2018, by and between the Company and Erik Ostrowski.

Similar stocks

Stock NameCountryMarket CapPE Ratio
REGENXBIO Inc. (RGNX)United States$0.477B-3.30
Entera Bio Ltd. (ENTX)$0.485B
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Autolus Therapeutics plc (AUTL)$0.506B-1.52
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Zura Bio Ltd (ZURA)$0.398B-6.56
Surrozen, Inc./DE (SRZN)United States$0.395B
AGENUS INC (AGEN)United States$0.383B1.41